- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | 1 | HKEx | ||
| CHINA BIOTECH SERVICES Aktie jetzt für 0€ handeln | |||||
| 30.09. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
| 30.09. | CH BIOTECH SER (08037): INTERIM REPORT 2026 | 1 | HKEx | ||
| 03.09. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - COOPERATION AGREEMENT IN RELATION TO CROSS-BORDER BNCT CLINICAL SERVICES | 2 | HKEx | ||
| 28.08. | CH BIOTECH SER (08037): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026 | - | HKEx | ||
| 13.08. | CH BIOTECH SER (08037): COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE ... | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): NOTICE OF BOARD MEETING | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): POSITIVE PROFIT ALERT | - | HKEx | ||
| 12.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - MASTER COLLABORATION AGREEMENT WITH STELLA PHARMA CORPORATION IN RELATION TO COMMERCIALISATION OF BNCT ... | 1 | HKEx | ||
| 07.08. | CH BIOTECH SER (08037): COMPLETION OF DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | 2 | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): COMPANY INFORMATION SHEET | - | HKEx | ||
| 03.08. | CH BIOTECH SER (08037): VOLUNTARY ANNOUNCEMENT - PRESENTATION OF INITIAL FOLLOW-UP FINDINGS OF BORON NEUTRON CAPTURE THERAPY AT THE 22ND CONGRESS ON NEUTRON ... | 2 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE CAPITAL IN PHC MEDICAL DIAGNOSTIC CENTRE LIMITED AND ... | 1 | HKEx | ||
| 30.06. | CH BIOTECH SER (08037): GRANT OF WAIVER UNDER RULE 19.41(A) OF THE GEM LISTING RULES AND FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): FURTHER DELAY IN DESPATCH OF THE CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO THE DISPOSAL OF THE ENTIRE ISSUED SHARE ... | - | HKEx | ||
| 26.06. | CH BIOTECH SER (08037): UPDATES ON DISCLOSEABLE TRANSACTION INVESTMENT IN A SUBSIDIARY OF THE COMPANY BY AN INVESTOR | - | HKEx | ||
| 16.06. | CH BIOTECH SER (08037): SUPPLEMENTAL ANNOUNCEMENT TO THE UPDATE ON EXEMPTED CONNECTED TRANSACTION IN RELATION TO THE ADOPTION OF SHARE AWARD SCHEME BY ... | - | HKEx | ||
| 15.06. | CH BIOTECH SER (08037): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 15 JUNE 2026 | - | HKEx |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 71,20 | -0,28 % | DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study | ||
| MCKESSON | 906,00 | +0,24 % | McKesson declares $0.94 dividend | ||
| MORE LIFE COMPANY | 0,032 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,82 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| AVEANNA HEALTHCARE | 12,990 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,330 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,110 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| GERRESHEIMER | 32,080 | 0,00 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.10.2026 / 13:52 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 18,390 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,445 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 | ||
| BILLIONTOONE | 104,58 | -0,09 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 68,95 | +0,01 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| STARLING ONCOLOGY INSTITUTE | 6,830 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROGYNY | 28,440 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report |
Das Unternehmen CHINA BIOTECH SERVICES HOLDINGS LTD kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA BIOTECH SERVICES HOLDINGS LTD finden Sie auf Wallstreet Online.